Italy DNA Vaccine market is anticipated to grow at a CAGR 41.3% during the forecast period. Most of Italy’s economy is driven by manufacturers of high-quality consumer goods produced by small and medium-sized enterprises. Similar to the UK and Germany the surviving infant rate in Italy is almost 100%. In 2017, the surviving infant rate was 484 out of 485. The major disease reported in the country is measles, rubella and tetanus. As per WHO, in 2017 the reported cases of the measles, mumps, pertussis were 4,050,508 and 510 respectively. No certain cases were reported for the following diseases from 2013 to 2016 expect measles. As per WHO, the major vaccinations scheduled in the country were aP, Diphtheria, DTaP, HepA, HepB, and Rotavirus. The government of Italy has made 12 vaccines mandatory for the children in May 2017. The mandatory vaccines include polio, diphtheria, tetanus, hepatitis B, Haemophilus influenzae B, meningitis B, meningitis C, measles, mumps, rubella, whooping cough and chickenpox.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/italy-dna-vaccines-market
Italy is a significant contributor to the Gavi Alliance since 2006. The country is focusing on health system strengthening, newborn and child health, along with communicable and non-communicable diseases, and mental health. The market is segmented on the basis of type, application, and technology. Based on type, the market is segmented into animal DNA vaccine and human DNA vaccine. Based on application, the market is segmented into oncology, infectious disease and others. Based on technology, the market is segmented into plasmid DNA vaccine and plasmid DNA delivery.
The key market players that are active in the market include Eli Lilly and Co., GE Healthcare, GlaxoSmithKline PLC., Inovio Pharmaceuticals Inc., Merck & Co., Novartis AG, Pfizer Inc., Roche Diagnostics GMBH and Sanofi Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.
A full report of Italy DNA Vaccine Market available @ https://www.omrglobal.com/industry-reports/italy-dna-vaccines-market
Italy DNA Vaccine Market Segmentation
By Type
- Animal DNA Vaccine
- Human DNA Vaccine
By Technology
- Plasmid DNA Vaccine
- Plasmid DNA Delivery
By Application
- Oncology
- Infectious Disease
- Others
Company Profiles
- Eli Lilly and Co.
- GE Healthcare
- Glaxosmithkline PLC.
- Inovio Pharmaceuticals Inc.
- Merck & Co.
- Novartis AG
- Pfizer Inc.
- Roche Diagnostics GMBH
- Sanofi Inc.
